<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00801814</url>
  </required_header>
  <id_info>
    <org_study_id>GIL-5051</org_study_id>
    <nct_id>NCT00801814</nct_id>
  </id_info>
  <brief_title>Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia</brief_title>
  <official_title>Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glycemic Index Laboratories, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InovoBiologic Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Center for Functional Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glycemic Index Laboratories, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine palatability and extent to which escalating doses of a novel highly viscous
      polysaccharide [NVP] reduces postprandial glycemia when added to a liquid and a solid meal.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postprandial glycemia</measure>
    <time_frame>Acute study measuring postprandial glucose levels over 2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber.</measure>
    <time_frame>Data analysis</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Blood Glucose, Postprandial</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>White Bread</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>White Bread and Margarine Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Glucose drink control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White bread and margarine
or
Glucose drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White bread and margarine
or
Glucose drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White bread and margarine
or
Glucose drink</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PolyGlycopleX (PGX)</intervention_name>
    <description>2.5 grams of PGX</description>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PolyGlycopleX (PG)</intervention_name>
    <description>5.0 grams of PGX</description>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PolyGlycopleX</intervention_name>
    <description>7.5 grams of PGX</description>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>0g of PGX</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Second Control</intervention_name>
    <description>0g of PGX</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals

          -  18-75 years old

          -  BMI less than 35 kg/m2

        Exclusion Criteria:

          -  Medications influencing gastrointestinal function

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra L Jenkins, PhD, RD</last_name>
    <role>Study Director</role>
    <affiliation>Glycemic Index Laboratories, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas MS Wolever, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glycemic Index Laboratories, Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glycemic Index Laboratories, Inc.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2008</study_first_submitted>
  <study_first_submitted_qc>December 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2008</study_first_posted>
  <last_update_submitted>December 3, 2008</last_update_submitted>
  <last_update_submitted_qc>December 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Alexandra Jenkins, PhD, RD/ Vice President</name_title>
    <organization>Glycemic Index Laboratories, Inc</organization>
  </responsible_party>
  <keyword>viscous</keyword>
  <keyword>fibre</keyword>
  <keyword>polysaccharide</keyword>
  <keyword>blood glucose</keyword>
  <keyword>post prandial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

